[Concurrent chemoradiation therapy with gemcitabine for advanced or relapsed pancreatic tumors].
Ioka
Tatsuya
T
Department of Hepatobiliary and Pancreatic Oncology, Osaka Medical Center for Cancer and CVD.
Nakaizumi
Akihiko
A
Tanaka
Sachiko
S
Yamazaki
Hideya
H
Nishiyama
Kinji
K
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D009367:Neoplasm Staging; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D011838:Radiation-Sensitizing Agents; D003841:Deoxycytidine; D000093542:Gemcitabine